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Table S1 Ions present in the HHCF and more than one composing botanical drugs.  







Source Proposed identity 
2.00 Positive 110 DIC, RHE, SCU, KOC NA 
2.34 Negative 195 RHE, SOP, SCU, PHE Gluconic acid/Galactonic 
acid 
2.58 Positive 136  DIC, RHE, SOP, SCU, KOC Adenine 
2.58 Positive 130 DIC, RHE, SOP, SCU, KOC Pyroglutamic acid 
2.77 Negative 133 RHE, SOP, SCU, PHE Malic acid 
2.77 Negative 115 RHE, SOP, SCU, PHE Fumaric acid 
3.25 Negative 191 RHE, SOP, SCU, PHE Citric acid/Isocitric acid 
3.25 Negative 111 RHE, SOP, SCU, PHE Fragment from citric 
acid/isocitric acid 
3.36 Positive 137  SCU, PHE, KOC Hypoxanthine/4-
Hydroxyacetophenone 
3.36 Positive 154 RHE, SCU, KOC Dopamine 




16.48 Negative 113 RHE, SOP, SCU, PHE NA 
17.01 Negative 113 RHE, SOP, SCU, PHE NA 
19.46 Negative 113 RHE, SCU, PHE NA 
26.65 Negative 113 RHE, SOP, SCU, PHE NA 
52.60 Negative 113 RHE, SOP, SCU, PHE NA 
88.26 Negative 113 RHE, SCU, PHE NA 















Table S2 Putatively identified compounds in the HHCF by LC-MS/MS in positive ionization mode. 
Rt  
(min) 
No. m/z Adduct ion(s) MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 




MSn=2-4 [191] (CE: 50%): 148(100) [1] 
3.36 P2 196 [M+NH4]
+ 196 (100%), 119 (67.72%), 137 (57.19%), 109 (2.33%), 151 (2.14%), 178 (0.83%), 
114 (0.63%), 153 (0.41%), 107 (0.3%), 110 (0.29%) 
PHE Aesculetin NA 
P3 205 [M+H]+ 205 (100%), 108 (1.79%), 110 (1.6%), 146 (1.57%), 162 (0.82%), 157 (0.67%), 990 
(0.63%), 164 (0.48%), 160 (0.42%), 147 (0.28%), 204 (0.26%), 134 (0.25%), 144 
(0.21%), 133 (0.18%), 161 (0.15%), 122 (0.13%), 148 (0.13%), 176 (0.13%) 
SOP N-Methylcytisine 
 
MS2 [205](CE: 10-30eV): 205, 162, 146, 
108, 58 [2] 
 
MSn=2-4 [205](CE: 50%): 146(91), 
108(100) [1] 
P4 215 [M+2Na-H]+ 215 (100%), 169 (54.49%), 142 (11.88%), 141 (9.18%), 125 (8.06%), 171 (7.82%), 
107 (5.42%), 112 (4.97%), 214 (3.64%), 136 (2.96%), 130 (2.47%) 
RHE Gallic acid MS2 (CE:45 V): 171 [3] 
3.75 P5 261 [M+H]+ 261 (100%), 114 (29.86%), 243 (3.4%), 164 (1.57%), 146 (0.6%), 166 (0.41%), 110 
(0.31%), 134 (0.31%), 148 (0.29%), 215 (0.25%), 122 (0.23%), 113 (0.22%), 162 
(0.2%), 108 (0.19%), 150 (0.17%), 152 (0.16%), 241 (0.15%), 156 (0.14%), 132 
(0.13%), 131 (0.12%), 120 (0.12%), 171 (0.11%), 260 (0.1%), 160 (0.09%), 172 
(0.09%), 200 (0.08%), 129 (0.07%), 138 (0.07%), 136 (0.05%), 109 (0.04%), 168 
(0.04%), 135 (0.04%), 133 (0.04%), 104 (0.03%), 225 (0.03%) 
SOP Baptifoline MSn=2-4[261](CE: 50%): 243(44), 164(24), 
114(100) [1] 
 
P6 265 [M+H]+ 265 (100%), 247 (2.98%), 263 (2.5%), 112 (2.49%), 164 (2.17%), 264 (2.1%), 245 
(1.92%), 166 (1.78%), 176 (1.59%), 236 (1.44%), 262 (1.44%), 148 (1.32%), 175 
(1.18%), 120 (0.93%), 163 (0.92%), 121 (0.79%), 131 (0.78%), 154 (0.75%), 124 
(0.73%), 123 (0.7%), 150 (0.65%), 136 (0.59%), 162 (0.54%), 219 (0.52%), 190 





EI-MS [265]: 264(87), 263(29), 247(100), 
246(24), 222(6), 221(26), 208(4), 193(10), 
166(15), 112(3), 120(35), 98(4), 96(36) [4] 
 
EI-MS (CE: NA): 264(59), 248(12), 
247(100), 245(45), 235(6), 222(12), 
221(29), 208(5), 193(12), 178(3), 166(16), 
153(6), 152(10), 148(12), 125(6), 112(30), 
96(36), 55(20), 41(18) [5] 
 
9α-Hydroxymatrine: 
MSn=2-4 [265] (CE: 50%): 247(52), 
150(63), 148(100), 112(20) [1] 
 
EI-MS (CE: NA): 264(100), 263(67), 
247(16), 246(5), 235(9), 222(10), 221(13), 
219(21), 208(15), 205(84), 193(19), 
178(8), 166(35), 164(22), 153(10), 
152(10), 114(11), 112(18), 98(9), 96(43), 
55(28), 41(24).[5] 
4.15 P7 265 [M+H]+ 265 (100%), 247 (7.28%), 150 (5.59%), 148 (5.25%), 112 (2.24%), 176 (1.29%), 122 
(1.15%), 188 (0.54%), 110 (0.49%), 120 (0.39%), 245 (0.36%), 136 (0.35%), 242 
(0.3%), 152 (0.29%), 162 (0.26%), 230 (0.25%), 202 (0.24%), 134 (0.23%), 217 
(0.22%), 201 (0.22%), 133 (0.22%), 263 (0.22%), 190 (0.2%), 127 (0.2%), 229 
(0.19%), 146 (0.18%), 219 (0.18%), 173 (0.16%), 131 (0.15%), 193 (0.15%), 145 
(0.15%), 161 (0.14%), 124 (0.14%), 138 (0.13%), 218 (0.13%), 121 (0.13%), 174 
(0.12%), 164 (0.12%), 168 (0.12%), 264 (0.12%), 204 (0.11%), 160 (0.1%), 179 
SOP 14β-
Hydroxymatrine 
EI-MS(CE: NA): 247, 246, 192, 177, 150, 
137, 136, 96 [6] 
 
EI-MS(CE: NA): 265(19), 264(100), 
263(72), 247(3), 246(4), 235(13), 222(48), 
221(55), 218(30), 193(57), 192(26), 
178(20), 177(19), 162(10), 150(29), 
Table S2 Putatively identified compounds in the HHCF by LC-MS/MS in positive ionization mode. 
Rt  
(min) 
No. m/z Adduct ion(s) MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
(0.06%), 132 (0.05%), 163 (0.05%), 153 (0.05%), 246 (0.05%), 108 (0.04%), 111 
(0.03%), 206 (0.03%), 200 (0.03%) 
149(15), 148(17), 137(14), 136(21), 
122(12), 109(8), 98(12), 96(33), 80(8), 
55(9), 41(11) [5] 
4.40 P8 180 [M+H]+ 121 (100%), 180 (16.62%), 103 (2.44%), 120 (0.11%), 151 (0.08%), 119 (0.05%) PHE Candicine MS2[180] (CE:NA): 150, 133, 122, 119, 
70 [7] 
 
MS2[180] (CE:NA): 121, 60; 
MS3(180121): 121, 103, 95, 93, 91, 77 
[8] 
4.75 P9 245 [M+H]+ 245 (100%), 150 (4.52%), 199 (3.76%), 162 (3.75%), 148 (3%), 158 (2.26%), 110 
(2.14%), 122 (2%), 124 (1.6%), 145 (1.54%), 175 (1.54%), 228 (1.33%), 105 (1.26%), 
174 (1.23%), 191 (1.2%), 136 (1.03%), 177 (0.94%), 125 (0.94%), 118 (0.93%), 217 
(0.89%), 160 (0.63%), 202 (0.52%), 227 (0.38%) 
SOP Anagyrine MSn=2-4 [245] (CE: 50%): 148(100), 
98(23) [1] 
 
P10 265 [M+H]+ 265 (100%), 168 (28.79%), 247 (8.6%), 150 (8.32%), 112 (3.93%), 148 (3.42%), 122 
(0.87%), 188 (0.81%), 176 (0.57%), 136 (0.53%), 230 (0.53%), 206 (0.29%), 131 
(0.25%), 160 (0.22%), 220 (0.21%), 134 (0.2%), 216 (0.2%), 124 (0.19%), 105 
(0.19%), 167 (0.18%), 263 (0.18%), 190 (0.17%), 140 (0.16%), 107 (0.16%), 135 
(0.16%), 204 (0.16%), 120 (0.15%), 195 (0.15%), 143 (0.13%), 248 (0.13%), 162 
(0.13%), 184 (0.13%), 166 (0.13%), 165 (0.12%), 138 (0.12%), 110 (0.12%), 164 
(0.12%), 229 (0.11%), 178 (0.11%), 132 (0.11%), 266 (0.1%), 100 (0.08%), 264 





EI-MS: 264(87), 263(29), 247(100), 
246(24), 222(6), 221(26), 208(4), 193(10), 
166(15), 112(3), 120(35), 98(4), 96(36) [4] 
 
EI-MS(CE: NA): 264(59), 248(12), 
247(100), 245(45), 235(6), 222(12), 
221(29), 208(5), 193(12), 178(3), 166(16), 
153(6), 152(10), 148(12), 125(6), 112(30), 
96(36), 55(20), 41(18) [5] 
 
9α-Hydroxymatrine: 
HPLC-IT-TOF, MSn=2-4(CE: 50%): 
247(52), 150(63), 148(100), 112(20) [1] 
 
EI-MS(CE: NA): 264(100), 263(67), 
247(16), 246(5), 235(9), 222(10), 221(13), 
219(21), 208(15), 205(84), 193(19), 
178(8), 166(35), 164(22), 153(10), 
152(10), 114(11), 112(18), 98(9), 96(43), 
55(28), 41(24).[5] 
5.00 P11 247 [M+H]+ 247 (100%), 150 (33.66%), 148 (10.26%), 188 (2.07%), 122 (1.78%), 158 (0.75%), 
105 (0.72%), 121 (0.7%), 134 (0.66%), 112 (0.61%), 149 (0.59%), 246 (0.58%), 110 
(0.44%), 176 (0.42%), 147 (0.32%), 160 (0.31%), 136 (0.26%), 245 (0.22%), 129 
(0.17%), 111 (0.15%) 
SOP 5,6-
Dehydrolupanine 
EI-MS(CE:45eV): 246(25), 148(6), 
134(9), 98(100), 97(38) [9] 
 
5.52 P12 263 [M+H]+ 150 (100%), 263 (41.59%), 148 (4.71%), 245 (3.13%), 128 (2.6%), 166 (2.52%), 125 
(1.94%), 175 (1.93%), 153 (1.61%), 122 (1.47%), 191 (1.39%), 164 (1.33%), 110 
(1.25%), 227 (1.22%), 119 (1.01%), 107 (0.97%), 235 (0.85%), 165 (0.84%), 146 
(0.84%), 171 (0.46%), 103 (0.4%), 130 (0.36%), 188 (0.36%), 121 (0.34%), 186 




Table S2 Putatively identified compounds in the HHCF by LC-MS/MS in positive ionization mode. 
Rt  
(min) 
No. m/z Adduct ion(s) MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
5.72 P13 192 [M+H]+ 192 (100%), 177 (42.56%), 149 (2.94%), 148 (2.54%), 176 (0.91%), 151 (0.48%), 147 
(0.43%), 163 (0.35%), 161 (0.33%), 174 (0.32%), 133 (0.19%), 159 (0.19%), 119 
(0.18%), 160 (0.16%), 132 (0.13%) 
PHE Noroxyhydrastinine MS2 [192] (CE:NA): 163, 160, 151, 60 [7] 
P14 249 [M+H]+ 249 (100%), 247 (1.8%), 148 (1.8%), 150 (0.81%), 112 (0.39%), 176 (0.33%), 110 
(0.26%), 136 (0.25%), 138 (0.2%), 152 (0.2%), 218 (0.15%), 231 (0.14%), 190 
(0.13%), 122 (0.12%), 166 (0.11%), 114 (0.11%), 204 (0.1%), 162 (0.09%), 232 
(0.05%), 199 (0.02%), 120 (0.02%), 134 (0.02%), 158 (0.01%), 149 (0.01%), 133 
(0.01%), 250 (0.01%), 147 (0%), 220 (0%) 





EI-MS(CE: NA): 249(8), 248(51), 
247(100), 219(2), 205(4), 192(1), 177(37), 
162(3), 150(28), 149(10), 148(9), 137(5), 
136(15), 122(5), 109(2), 98(3), 96(7), 
55(5), 41(4) [5] 
 
Matrine: 
MSn=2-4 [249] (CE: 50%): 176(100), 
150(10), 148(5) [1] 
 
Isomatrine: 
MSn=2-4 [249] (CE: 50%): 176(100), 
150(15), 148(10) [1] 
 
Sophoridine: 
MSn=2-4 [249] (CE: 50%): 176(100), 
150(15), 148(10) [1] 
519 [2M+Na]+ 271 (100%), 519 (1.67%), 314 (0.27%), 272 (0.15%) 
497 [2M+H]+ 249 (100%), 351 (0.77%), 247 (0.44%), 150 (0.29%), 121 (0.11%) 
271 [M+Na]+ No fragment ion 
6.47 P15 247 [M+H]+ 247 (100%), 179 (6.18%), 245 (5.01%), 136 (3.66%), 150 (2.64%), 148 (0.75%), 229 
(0.62%), 138 (0.56%), 110 (0.37%), 152 (0.3%), 122 (0.27%), 108 (0.26%), 230 
(0.25%), 174 (0.23%), 149 (0.21%), 176 (0.2%), 134 (0.19%), 112 (0.17%), 162 
(0.15%), 164 (0.14%), 188 (0.13%), 146 (0.13%), 216 (0.1%), 228 (0.1%), 226 
(0.1%), 204 (0.09%), 218 (0.04%), 144 (0.04%), 178 (0.04%), 227 (0.04%), 131 
(0.03%), 105 (0.02%), 201 (0.01%) 
SOP Sophocarpine OR 
Isosophocarpine 
Sophocarpine: 
MSn=2-4 [247] (CE: 50%): 227(19), 
179(100), 150(93), 148(40), 136(63) [1] 
 
Isosophocarpine: 
MSn=2-4 [247] (CE: 50%): 179(100), 
150(90), 148(51), 136(72) [1] 
P16 249 [M+H]+ 249 (100%), 150 (0.59%), 152 (0.55%), 247 (0.5%), 112 (0.36%), 148 (0.32%), 180 
(0.22%), 136 (0.18%), 178 (0.18%), 176 (0.16%), 110 (0.15%), 190 (0.13%), 122 
(0.11%), 218 (0.1%), 138 (0.09%), 220 (0.08%), 135 (0.08%), 231 (0.07%), 120 
(0.06%), 162 (0.06%), 114 (0.06%), 124 (0.03%), 106 (0.03%), 166 (0.03%), 195 
(0.02%), 149 (0.01%), 174 (0.01%), 131 (0.01%), 186 (0.01%), 177 (0.01%) 





EI-MS(CE: NA): 249(8), 248(51), 
247(100), 219(2), 205(4), 192(1), 177(37), 
162(3), 150(28), 149(10), 148(9), 137(5), 
136(15), 122(5), 109(2), 98(3), 96(7), 
55(5), 41(4) [5] 
 
Matrine: 
MSn=2-4 [249] (CE: 50%): 176(100), 
150(10), 148(5) [1] 
 
Isomatrine: 
MSn=2-4 [249] (CE: 50%): 176(100), 
150(15), 148(10) [1] 
 
Sophoridine: 
519 [2M+Na]+ 271 (100%), 272 (1.89%), 519 (1.3%), 273 (1.09%), 270 (0.51%), 269 (0.25%) 
497 [2M+H]+ 249 (100%), 250 (3.68%), 251 (2.71%), 248 (0.82%), 247 (0.6%), 232 (0.59%), 120 
(0.42%), 283 (0.24%) 
Table S2 Putatively identified compounds in the HHCF by LC-MS/MS in positive ionization mode. 
Rt  
(min) 
No. m/z Adduct ion(s) MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
HPLC-IT-TOF, MSn=2-4(CE: 50%): 
176(100), 150(15), 148(10) [1] 
8.02 P17 263 [M+H]+ 263 (100%), 245 (16.22%), 150 (4.09%), 136 (3.05%), 138 (2.57%), 246 (2.44%), 203 
(2.43%), 177 (1.41%), 110 (1.33%), 137 (1.14%), 148 (0.88%), 159 (0.79%), 149 
(0.72%), 122 (0.58%), 134 (0.55%), 162 (0.49%), 217 (0.48%), 231 (0.48%), 227 
(0.47%), 195 (0.44%), 228 (0.39%), 160 (0.38%), 161 (0.36%), 174 (0.35%), 218 
(0.34%), 109 (0.32%), 146 (0.31%), 124 (0.3%), 186 (0.3%), 135 (0.29%), 191 
(0.27%), 151 (0.27%), 178 (0.26%), 163 (0.19%), 202 (0.19%), 189 (0.19%), 147 
(0.19%), 187 (0.18%), 108 (0.18%), 112 (0.18%), 131 (0.15%), 166 (0.15%), 188 
(0.15%), 176 (0.15%), 190 (0.15%), 132 (0.15%), 123 (0.15%), 175 (0.14%), 164 
(0.13%), 200 (0.12%), 111 (0.11%), 216 (0.11%), 205 (0.1%), 204 (0.1%), 229 
(0.1%), 243 (0.1%), 120 (0.1%), 168 (0.09%), 130 (0.08%), 172 (0.08%), 125 
(0.08%), 133 (0.07%), 265 (0.05%), 121 (0.04%), 139 (0.03%), 201 (0.02%), 165 
(0.02%), 262 (0.01%), 261 (0.01%), 157 (0.01%), 106 (0.01%), 158 (0.01%), 142 
(0.01%), 235 (0.01%) 
SOP Oxysophocarpine  MSn=2-4 [263] (CE: 50%): 245(100), 
150(53), 138(39) [1] 
525 [2M+H]+ 263 (100%), 525 (1.69%), 245 (0.44%), 465 (0.24%), 246 (0.14%), 265 (0.14%), 150 
(0.12%), 393 (0.09%), 136 (0.07%), 149 (0.06%), 203 (0.05%), 331 (0.04%), 138 
(0.04%) 
P18 265 [M+H]+ 265 (100%), 247 (6.37%), 205 (4.4%), 148 (3.69%), 136 (2.5%), 248 (2.21%), 137 
(1.65%), 150 (1.57%), 162 (0.97%), 206 (0.92%), 220 (0.91%), 176 (0.86%), 177 
(0.74%), 219 (0.61%), 112 (0.59%), 161 (0.41%), 120 (0.4%), 192 (0.36%), 149 
(0.33%), 133 (0.33%), 124 (0.29%), 122 (0.23%), 190 (0.23%), 110 (0.2%), 134 
(0.18%), 138 (0.18%), 178 (0.17%), 233 (0.16%), 188 (0.15%), 108 (0.14%), 151 
(0.14%), 164 (0.14%), 189 (0.13%), 135 (0.13%), 204 (0.12%), 109 (0.12%), 163 
(0.11%), 235 (0.11%), 174 (0.1%), 160 (0.1%), 191 (0.1%), 230 (0.09%), 202 
(0.08%), 146 (0.04%), 152 (0.03%), 139 (0.03%), 245 (0.02%), 111 (0.02%), 264 
(0.02%), 179 (0.01%), 217 (0.01%), 123 (0.01%), 107 (0.01%), 105 (0.01%), 229 
(0.01%), 207 (0.01%), 175 (0.01%), 203 (0.01%) 
SOP Oxymatrine OR 
Oxysophoridine 
Oxymatrine: 
MSn=2-4 [265] (CE: 50%): 265(100), 
247(26), 205(35), 148(53) [1] 
 
 
529 [2M+H]+ 265 (100%), 529 (1.03%), 247 (0.34%), 248 (0.26%), 176 (0.2%), 264 (0.2%), 205 
(0.17%), 266 (0.17%), 263 (0.15%), 206 (0.15%), 220 (0.11%), 148 (0.1%), 136 
(0.07%), 137 (0.07%), 267 (0.04%) 
P19 266 [M+NH4]
+ 266 (100%), 248 (6.66%), 206 (4.05%), 249 (2.99%), 137 (2.95%), 149 (2.86%), 148 
(1.78%), 151 (1.43%), 205 (1.37%), 138 (1.31%), 177 (1.24%), 136 (1.21%), 150 
(1.1%), 221 (1.05%), 207 (0.96%), 220 (0.85%), 178 (0.8%), 162 (0.69%), 265 
(0.63%), 163 (0.59%), 112 (0.5%), 110 (0.45%), 121 (0.41%), 193 (0.38%), 134 
(0.36%), 120 (0.32%), 189 (0.3%), 123 (0.29%), 176 (0.28%), 113 (0.28%), 133 
(0.25%), 124 (0.24%), 234 (0.23%), 161 (0.23%), 122 (0.2%), 135 (0.2%), 192 
(0.19%), 165 (0.19%), 247 (0.19%), 139 (0.19%), 106 (0.19%), 164 (0.18%), 219 
(0.17%), 179 (0.17%), 236 (0.17%), 204 (0.16%), 231 (0.15%), 152 (0.15%), 111 
(0.14%), 107 (0.14%), 190 (0.13%), 108 (0.13%), 175 (0.13%), 171 (0.11%), 125 
(0.11%), 109 (0.11%), 147 (0.11%), 167 (0.1%), 232 (0.1%), 230 (0.1%), 132 




EI-MS(CE:45eV): 248(45), 150(38), 
149(58), 136(100), 98(28) [9] 
10.42 P20 247 [M+H]+ 247 (100%), 148 (76.77%), 176 (14.81%), 150 (7.33%), 110 (2.34%), 179 (2.13%), 
229 (2.11%), 218 (1.57%), 190 (1.49%), 120 (1.48%), 230 (1.46%), 206 (1.42%), 188 




MSn=2-4 [247] (CE: 50%): 176(100), 
148(13) [1] 
Table S2 Putatively identified compounds in the HHCF by LC-MS/MS in positive ionization mode. 
Rt  
(min) 
No. m/z Adduct ion(s) MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
(1.01%), 134 (0.91%), 165 (0.86%), 212 (0.84%), 157 (0.81%), 133 (0.72%), 204 
(0.69%), 160 (0.61%), 132 (0.59%), 174 (0.57%), 186 (0.54%), 164 (0.52%), 216 
(0.51%), 202 (0.49%), 105 (0.48%), 127 (0.47%), 111 (0.41%), 123 (0.4%), 124 
(0.39%), 136 (0.37%), 162 (0.36%), 131 (0.35%), 245 (0.33%), 130 (0.32%), 113 
(0.3%), 138 (0.28%), 161 (0.27%), 147 (0.26%), 159 (0.22%), 203 (0.2%), 119 
(0.19%), 135 (0.19%), 173 (0.19%), 189 (0.18%), 137 (0.16%), 108 (0.15%), 106 
(0.15%) 
11.30 P21 263 [M+H]+ 263 (100%), 245 (20.1%), 112 (9.14%), 235 (5.4%), 246 (5.34%), 195 (2.93%), 204 
(2.77%), 149 (2.76%), 136 (2.1%), 218 (1.98%), 148 (1.64%), 162 (1.58%), 120 
(1.4%), 138 (1.36%), 135 (1.19%), 122 (1.17%), 110 (1.02%), 180 (1%), 134 (1%), 
191 (0.99%), 166 (0.91%), 202 (0.79%), 111 (0.74%), 200 (0.7%), 176 (0.68%), 146 
(0.64%), 173 (0.59%), 159 (0.59%), 106 (0.57%), 124 (0.57%), 217 (0.57%), 177 





MSn=2-4 [263] (CE: 50%): 245(33), 164 
(100) [1] 
 
EI-MS(CE: NA): 262(77), 261(100), 
245(12), 233(5), 219(6), 217(10), 203(25), 
193(19), 166(30), 154(19), 153(6), 
152(11),, 136(15), 122(9), 144(6), 
112(14), 110(18), 109(8), 98(3), 96(37), 
92(2), 68(23), 41(24).[5] 
11.48 P22 263 [M+H]+ 263 (100%), 164 (20.48%), 245 (19.12%), 246 (12.69%), 218 (6.89%), 204 (6.55%), 
150 (4.09%), 176 (3.22%), 148 (3.14%), 166 (2.31%), 175 (2.03%), 190 (1.7%), 134 
(1.39%), 146 (1.18%), 202 (1.07%), 152 (0.87%), 186 (0.85%), 136 (0.83%), 217 
(0.77%), 188 (0.75%), 162 (0.73%), 203 (0.66%), 165 (0.64%), 147 (0.59%), 112 
(0.57%), 180 (0.57%), 174 (0.55%), 108 (0.54%), 155 (0.52%), 160 (0.45%), 133 
(0.43%), 189 (0.42%), 264 (0.42%), 122 (0.4%), 231 (0.39%), 138 (0.37%), 178 
(0.26%), 179 (0.24%), 243 (0.2%), 200 (0.17%), 130 (0.16%), 161 (0.15%), 124 




MSn=2-4 [263] (CE: 50%): 195(82), 
166(100) [1] 
525 [2M+H]+ NA 
P23 265 [M+H]+ 265 (100%), 247 (17.02%), 205 (6.84%), 248 (5.94%), 150 (3.38%), 177 (2.27%), 137 
(2.04%), 206 (1.61%), 220 (1.57%), 136 (1.53%), 148 (1.48%), 151 (1.35%), 149 
(0.82%), 162 (0.74%), 219 (0.73%), 152 (0.71%), 138 (0.46%), 192 (0.4%), 176 
(0.38%), 124 (0.38%), 161 (0.35%), 112 (0.32%), 122 (0.29%), 120 (0.28%), 165 
(0.23%), 133 (0.23%), 175 (0.22%), 160 (0.19%), 166 (0.18%), 164 (0.18%), 204 
(0.18%), 191 (0.18%), 111 (0.16%), 109 (0.16%), 194 (0.16%), 135 (0.14%), 110 
(0.13%), 218 (0.12%), 134 (0.11%), 189 (0.1%), 168 (0.1%) 
SOP Oxymatrine OR 
Oxysophoridine 
Oxymatrine: 
MSn=2-4 [265] (CE: 50%): 265(100), 
247(26), 205(35), 148(53) [1] 
 
529 [2M+H]+ NA  
11.88 P24 243 [M+H]+ OR 
[M]+ 







20.08 P25 342 [M+H]+ 192 (100%), 342 (19.81%), 177 (6.11%) PHE Tetrahydrojatrorrhiz
ine 
MS2 [342] (CE:NA): 342, 298, 249, 192, 
177, 145 [7] 
21.12 P26 344 [M+NH4]
+ 107 (100%), 165 (15.81%), 145 (7.02%), 403 (6.68%), 192 (5.09%), 344 (4.14%), 193 






Table S2 Putatively identified compounds in the HHCF by LC-MS/MS in positive ionization mode. 
Rt  
(min) 
No. m/z Adduct ion(s) MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
P27 349 [M+NH4]
+ 349 (100%), 185 (1.85%), 187 (1.53%), 291 (0.65%), 257 (0.35%), 259 (0.29%), 247 




22.08 P28 344 [M+H]+ 344 (100%), 175 (16.68%), 299 (15.38%), 137 (14.51%), 301 (7.39%), 151 (6.26%), 
143 (5.14%), 267 (2.52%), 269 (1.98%), 192 (1.42%), 312 (1.38%), 177 (1.24%), 107 
(1.2%), 207 (1.1%), 193 (1.08%), 241 (1.05%), 239 (1.04%), 115 (0.66%), 235 
(0.65%), 194 (0.6%), 145 (0.46%), 206 (0.44%), 237 (0.43%), 160 (0.43%), 163 
(0.41%), 179 (0.41%), 119 (0.35%), 117 (0.35%), 329 (0.31%), 284 (0.31%), 209 
(0.3%), 213 (0.29%), 294 (0.29%), 162 (0.28%), 205 (0.28%), 149 (0.26%), 272 
(0.26%), 123 (0.24%), 131 (0.24%), 251 (0.23%), 180 (0.2%), 176 (0.2%), 118 
(0.19%), 271 (0.19%), 109 (0.19%), 153 (0.18%), 122 (0.18%), 182 (0.17%), 187 
(0.16%), 178 (0.15%), 161 (0.15%), 268 (0.15%), 125 (0.15%), 252 (0.14%), 223 
(0.14%), 255 (0.14%), 188 (0.14%), 174 (0.13%), 165 (0.13%), 253 (0.13%), 181 






MS2 [344] (CE:NA): 343, 222, 209, 192, 
163, 95 [7] 
22.91 P29 342 [M+H]+ 342 (100%), 192 (65.27%), 130 (44.39%), 265 (38.79%), 297 (30.11%), 116 
(23.34%), 203 (18.44%), 298 (16.58%), 300 (15.05%), 237 (7.11%), 282 (6.16%), 107 








MS2[342] (CE:NA): 325, 313, 311, 298, 
293, 290, 287 [7] 
24.33 P30 592 [2M+NH4+H]
+ 592 (100%), 163 (13.44%), 286 (5.69%), 382 (3.82%) PHE Rutecarpine NA 
26.84 P31 314 [M+H]+ 314 (100%), 107 (333.67%), 269 (204.1%), 143 (95.44%), 137 (82.51%), 121 
(56.43%), 115 (41.17%), 175 (26.19%), 271 (28.98%), 145 (11.62%), 237 (30.37%), 
147 (16.78%), 191 (29.59%), 251 (7.9%), 194 (7.67%), 163 (11.95%), 146 (12.06%), 
177 (5.97%), 193 (5.82%), 178 (4.46%), 209 (4.43%) 
PHE Evoeuropine NA 




MS2 [356] (CE:NA): 261, 260, 242, 177 
[7] 
52.87 P33 366 [M]+ 336 (100%), 321 (26.43%), 320 (14%), 292 (13.06%), 306 (2.64%), 335 (1.54%), 304 
(1.41%), 278 (1.37%), 275 (1.11%), 318 (0.51%) 
PHE Berberine MS2 [336] (CE:NA): 321, 306, 278 [10] 
 







Table S3 Putatively identified compounds in the LC-MS/MS in negative ionization mode. 
Rt  
(min) 
No. m/z Adduct 
ion(s) 
MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
2.34 N1 193 [M-H]- 113 (100%), 103 (39.1%), 101 (15.01%) SCU Glucuronic acid NA 
2.46 N2 191 [M-H]- 191 (100%), 127 (7.66%), 111 (4.1%), 173 (3.01%), 109 (2.98%), 145 (2.25%), 
190 (2.16%), 171 (1.96%), 103 (1.05%), 129 (0.97%), 143 (0.79%) 
PHE Quinic acid MS2 [191] (CE:NA): 173, 127, 111, 93, 
85 [12] 
N3 223 [M-H]- 129 (100%), 111 (79.45%), 205 (47.14%), 101 (46.72%), 125 (37.99%), 223 
(26.17%) 
SOP Sinapiic acid NA 
3.50 N4 191 [M-H]- 111 (100%), 131 (7.5%), 129 (2.94%), 191 (2.19%), 190 (1.49%), 155 (1.41%) PHE Citric acid MS2 [191] (CE:NA): 173, 111 [12] 
N5 331 [M-H]- 169 (100%), 211 (76.8%), 331 (43.3%), 125 (29.19%), 124 (21.17%), 123 
(11.69%), 151 (9.12%), 167 (8.78%), 193 (8.31%), 168 (8.19%), 271 (8.09%), 
112 (7.95%), 113 (7.03%), 119 (5.65%), 128 (4.98%), 183 (4.9%), 241 (4.72%), 
101 (4.19%), 286 (2.89%), 107 (2.07%), 210 (1.41%), 270 (1.41%), 137 (1.13%) 








Glucopyranosyloxyl gallic acid: 




MS2 [331] (CE:50%):169(100) [14] 
 
Galloylglucose: 
MS2 [331] (CE:NA): 169, 125 [15] 
4.08 N6 331 [M-H]- 169 (100%), 123 (38.65%), 331 (38.36%), 151 (34.32%), 125 (27.77%), 211 
(26.08%), 271 (20.32%), 113 (8.98%), 183 (8.02%), 124 (5.04%), 241 (4.82%), 
168 (4.77%), 101 (4.67%), 119 (3.85%), 107 (3.65%), 210 (3.33%), 153 (3.14%), 
197 (2.41%), 167 (2.12%), 193 (2.06%), 162 (1.17%), 152 (0.76%), 165 (0.57%) 
RHE 
4.61 N7 331 [M-H]- 211 (100%), 271 (96.85%), 169 (84.6%), 125 (24.42%), 168 (19.07%), 124 
(16.25%), 107 (9.53%), 331 (7.91%), 241 (4.09%), 165 (4.05%), 123 (3.53%), 
151 (3.14%), 197 (1.89%), 139 (1.59%), 167 (1.58%), 270 (1.56%), 183 (1.31%), 
101 (1.03%), 113 (0.88%) 
RHE 
5.35 N8 125 [M-H]- 125 (100%), 124 (13.85%) RHE Pyrogallol NA 
N9 169 [M-H]- 125 (100%), 169 (8.42%), 107 (3.58%), 124 (3.27%) RHE Gallic acid MS2 [169] (CE:30-50V): 125, 107 [13] 
N10 331 [M-H]- 211 (100%), 169 (66.81%), 271 (62.68%), 125 (21.96%), 331 (15.26%), 193 
(12.23%), 124 (11.97%), 151 (10.94%), 241 (10.24%), 123 (7.63%), 103 
(6.98%), 168 (4.58%), 183 (4.56%), 167 (3.64%), 113 (2.85%), 107 (1.27%) 








Glucopyranosyloxyl gallic acid: 




MS2 [331] (CE:50%):169(100) [14] 
 
Galloylglucose: 
MS2 [331] (CE:NA): 169, 125 [15] 
8.71 N11 255 [M-H]- 165 (100%), 107 (38.58%), 179 (32.86%), 133 (22.4%), 193 (17.87%), 149 
(16.97%), 147 (16.65%), 255 (13.5%), 131 (10.06%), 135 (8.43%), 119 (7.46%), 
105 (3.15%), 175 (2.9%), 163 (2.02%), 211 (1.85%), 121 (1.8%), 137 (1.56%), 
132 (1.55%), 181 (1.4%), 103 (1.23%), 151 (1.06%), 130 (1.05%), 134 (0.98%), 
106 (0.98%), 162 (0.62%), 150 (0.6%), 109 (0.31%) 
SOP Piscidic acid MS2 [276] (CE:NA): 211(33), 193(96), 
179(90), 165(87), 149(57) [16] 511 [2M-H]- 
13.88 N12 577 [M-H]- 289 (100%), 407 (65.72%), 125 (38.87%), 425 (22.46%), 577 (19.45%), 245 
(14.76%), 451 (13.65%), 305 (9.9%), 161 (9.42%), 287 (7.36%), 273 (7.08%), 
381 (5.51%), 137 (5.37%), 205 (4.92%), 299 (4.55%), 559 (4.07%), 151 (3.55%), 
175 (3.43%), 243 (3.16%), 255 (2.83%), 203 (2.77%), 450 (2.51%), 256 (2.43%), 
163 (2.25%), 328 (2.19%), 329 (2.1%), 229 (2.05%), 109 (2%), 339 (1.99%), 179 
(1.92%), 269 (1.85%), 283 (1.74%) 
RHE Procyanidin B (Catechin 
dimers) 
MS2 [577] (CE:30-50V): 407, 289, 245, 
125, 109 [13] 
16.48 N13 289 [M-H]- 109 (100%), 123 (91.31%), 203 (82.01%), 151 (66.21%), 245 (56.6%), 125 
(55.02%), 137 (47.19%), 205 (40.11%), 289 (35.92%), 149 (31.13%), 121 
(30.99%), 221 (30.71%), 179 (29.9%), 188 (29.79%), 161 (25.5%), 165 
(22.74%), 175 (22.34%), 187 (21.66%), 164 (20.04%), 202 (17.32%), 227 
RHE Catechin MS2 [298] (CE:30-50V): 271, 245, 125, 
109 [13] 
 
Table S3 Putatively identified compounds in the LC-MS/MS in negative ionization mode. 
Rt  
(min) 
No. m/z Adduct 
ion(s) 
MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
(16.9%), 247 (16.8%), 135 (12.93%), 199 (12.77%), 162 (11.73%), 167 
(11.33%), 139 (11.08%), 159 (11.03%), 231 (10.45%), 173 (10.2%), 217 
(9.78%), 145 (9.56%), 122 (8.76%), 157 (8.68%), 244 (8.36%), 163 (8.17%), 147 
(7.96%), 158 (7.31%), 160 (7.14%), 212 (7.09%), 220 (7.09%), 201 (7%), 230 
(6.97%), 117 (6.91%), 204 (6.8%), 138 (5.62%), 150 (5.44%), 177 (5.21%), 178 
(5.17%), 185 (5.15%), 174 (4.93%), 107 (4.67%), 131 (4.61%), 271 (4.54%), 184 
(4.46%), 166 (4.43%), 186 (3.81%), 183 (3.56%), 108 (2.94%), 226 (2.18%), 146 
(2.03%), 211 (2.02%), 209 (1.94%), 229 (1.75%), 176 (1.54%), 113 (1.51%), 133 
(1.26%), 111 (1.21%) 
MS2 [298] (CE:50%): 109(100), 152(40), 
123(60) [14] 
579 [2M-H]- 289 (100%), 245 (13.19%), 125 (3.06%), 179 (2.62%), 203 (2.41%), 205 
(2.13%), 137 (1.79%), 109 (1.52%), 271 (1.19%), 187 (1.04%), 135 (1.01%), 217 
(0.98%), 123 (0.96%), 175 (0.9%), 165 (0.85%), 151 (0.75%), 221 (0.74%), 247 
(0.6%), 149 (0.51%), 227 (0.44%), 188 (0.44%), 161 (0.43%), 204 (0.41%), 160 
(0.37%), 200 (0.3%), 121 (0.25%), 167 (0.19%), 164 (0.19%) 
N14 353 [M-H]- 191 (100%), 205 (2.98%), 127 (1.69%), 109 (0.83%), 265 (0.79%), 135 (0.63%), 
161 (0.62%), 173 (0.49%), 179 (0.29%), 111 (0.24%) 
PHE Chlorogenic acid MS2 [353] (CE:20eV): 191, 173, 135, 
127, 111 [17] 
707 [2M-H]- NA 
18.15 N15 367 [M-H]- 193 (100%), 134 (52.75%), 149 (8.46%), 117 (6.01%), 191 (3.98%), 173 
(3.75%), 155 (3.02%), 367 (2.41%), 109 (1.95%), 116 (1.9%), 111 (1.28%), 154 
(0.87%), 190 (0.62%), 148 (0.43%) 
PHE 3-O-Feruloylquinic acid MS2 [337] (CE:NA): 193(100), 191(1.8), 
173(3.3), 134(4.5) [18] 
 




MS2 [325] (CE:50%): 163(100), 57(45) 
[14] 
 
MS2 [325] (CE:15-35V): 161 [19] 
371 [M+FA-H]- 163 (100%), 121 (39.46%), 162 (12.41%), 113 (8.94%), 101 (7.9%), 161 (4.17%) 
651 [2M-H]- NA 
N17 415 [M+Na-2H]- NA RHE 6-Hydroxymusizin-8-O- β-
D-glucoside 
MS2 [393] (CE:50%): 231(100) [14] 
439 [M+FA-H]- 231 (100%), 113 (77.31%), 393 (11.6%) 
22.77 N18 289 [M-H]- 123 (100%), 109 (99.46%), 125 (63.81%), 203 (60.91%), 245 (45.97%), 205 
(42.45%), 151 (36.41%), 289 (32.34%), 137 (31.47%), 221 (31.24%), 188 
(24.48%), 159 (23.6%), 161 (23.03%), 175 (21.4%), 121 (19.64%), 163 
(17.76%), 146 (17.55%), 122 (17.39%), 149 (14.55%), 187 (14%), 185 (13.59%), 
145 (12.8%), 164 (11.92%), 139 (11.92%), 165 (10.61%), 217 (10.16%), 162 
(9.71%), 227 (8.78%), 230 (8.05%), 138 (8.01%), 135 (7.29%), 179 (7.27%), 202 
(6.52%), 174 (6.35%), 167 (6.1%), 199 (5.73%), 229 (5.42%), 143 (4.53%), 186 
(4.17%), 244 (4.17%), 201 (4.02%) 
RHE Epicatechin 
 
MS2 [289] (CE:30-50V): 245, 125, 109 
[13] 
N19 337 [M-H]- 191 (100%), 163 (10.21%), 173 (7.7%), 119 (6.74%), 111 (4.09%), 129 (2.45%), 
143 (1.65%), 172 (1.28%), 142 (0.78%) 
PHE  p-coumaroylquinic acid 
(not previously reported in 
Phellodendron) 
 
 3-O-p-Coumaroylquinic acid 
MS2 [337] (CE:NA): 191(7.6), 163(100), 
119(3.9) 
4-O-p-Coumaroylquinic acid 
MS2 [337] (CE:NA): 191(6.4), 173(100), 
163(7.2) 
5-O-p-Coumaroylquinic acid 
Table S3 Putatively identified compounds in the LC-MS/MS in negative ionization mode. 
Rt  
(min) 
No. m/z Adduct 
ion(s) 
MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
MS2 [337] (CE:NA): 191(100), 163(7.1) 
[18] 
24.72 N20 303 [M-H]- 125 (100%), 177 (29.2%), 149 (17.35%), 151 (13.92%), 217 (8.99%), 124 
(7.9%), 165 (7.78%), 213 (7.67%), 175 (7.13%), 123 (6.97%), 193 (6.77%), 285 
(4.74%), 199 (4.16%), 121 (3.99%), 173 (3.31%), 303 (3.07%), 197 (2.61%), 189 
(2.47%), 241 (2.43%), 133 (2.29%), 243 (2.15%), 107 (1.77%), 152 (1.75%), 145 
(1.61%), 275 (1.61%), 120 (1.55%), 212 (1.27%), 147 (1.26%), 164 (1.19%), 148 




MS2 [303] (CE:NA): 285, 276, 259, 217, 
177 [20] 
26.26 N21 367 [M-H]- 191 (100%), 173 (41.26%), 193 (18.5%), 134 (11.18%), 111 (8.15%), 155 
(4.26%), 178 (3.62%), 149 (3.53%), 143 (3.1%), 175 (2.27%), 113 (2.05%), 137 
(1.84%), 160 (1.78%), 129 (1.77%), 127 (1.74%), 101 (1.33%), 117 (1.25%), 192 
(1%), 136 (0.64%), 116 (0.63%), 115 (0.58%), 171 (0.36%) 
PHE 5-O-Feruloylquinic acid MS2 [337] (CE:NA): 193(6.0), 191(100), 
173(2.2), 134(4.5) [18] 
26.65 N22 389 [M-H]- NA RHE Resveratrol-4'-O-β-D-
glucoside OR Resveratrol 
3-O-β-glucoside (Pieceid) 
 
MS2 [389] (CE:15-35V): 227, 185, 143 
[19] 
 
435 [M+FA-H]- 227 (100%), 191 (9.41%), 389 (3.8%), 225 (2.18%), 173 (1.57%), 367 (1.44%), 
374 (1.42%), 185 (1.08%), 193 (0.64%), 228 (0.43%) 
779 [2M-H]- NA 
825 [2M+FA-H]- NA 
N23 503 [M-H]- 113 (100%), 389 (59.12%), 191 (19.03%) RHE Melezitose MS2 [503] (CE:30-50V): 179, 161, 131, 
113 [13] 584 [M+Br]- NA 
28.16 N24 229 [M-H]- 229 (100%), 185 (45.31%), 139 (33.76%), 183 (28.24%), 167 (20.83%), 137 
(18.63%), 211 (9.9%), 165 (9.23%), 155 (8.91%), 117 (7.3%), 149 (4.12%), 113 
(3.63%), 111 (2.36%) 
PHE Osthenol NA 
32.06 N25 301 [M-H]- 125 (100%), 149 (66.53%), 151 (64.68%), 148 (35.07%), 301 (29.63%), 175 
(26.33%), 283 (24.01%), 107 (22.49%), 147 (18.18%), 152 (14.15%), 201 
(8.59%), 171 (8.31%), 192 (8.15%), 121 (8.09%), 135 (7.67%), 229 (7.09%), 213 
(6.53%), 187 (6.25%), 215 (5.98%), 119 (5.9%), 177 (5.81%), 257 (5.67%), 163 
(5.57%), 105 (5.44%), 109 (5.24%), 211 (5.21%), 239 (5.12%), 205 (4.94%), 227 
(4.85%), 176 (3.14%), 161 (2.76%), 153 (2.62%), 159 (2.53%), 189 (2.48%), 195 
(2.44%), 203 (2.43%), 273 (2.42%), 120 (2.41%), 272 (2.37%), 185 (2.29%), 214 
(2.26%), 137 (2.21%), 233 (1.79%), 245 (1.73%), 216 (1.6%), 255 (1.56%), 160 





MS2 [345] (CE:NA): 383, 273, 257, 229, 
151 [20] 
34.57 N26 441 [M-H]- 169 (100%), 289 (50.74%), 125 (35.13%), 245 (17.94%), 271 (12.85%), 203 
(12.14%), 137 (8.9%), 253 (8.3%), 193 (7.68%), 205 (7.38%), 331 (7.28%), 179 
(6.31%), 151 (6.2%), 441 (6%), 124 (5.44%), 303 (5.34%), 166 (4.44%), 288 
(4.14%), 287 (3.83%), 168 (3.31%), 227 (2.89%), 175 (2.76%), 259 (2.65%), 145 
(2.65%), 109 (2.41%), 123 (2.38%), 221 (2.19%), 204 (1.99%), 397 (1.82%), 150 
(1.82%), 167 (1.81%), 184 (1.77%), 185 (1.39%), 165 (1.31%), 315 (1.22%), 192 
(1.04%), 188 (1.04%), 161 (0.91%), 164 (0.87%) 
RHE Epicatechin 3-O-gallate 
 
MS2 [441] (CE:50%): 289(100), 109 [14] 
N27 477 [M-H]- 477 (100%), 169 (40.95%), 313 (35.4%), 125 (11.02%), 151 (7.41%), 124 
(5.6%), 289 (3.44%), 123 (3.28%), 168 (3.05%), 441 (2.8%), 161 (2.22%), 163 
(1.95%), 245 (1.95%), 241 (1.89%), 211 (1.36%), 167 (1.25%), 101 (1.16%), 295 
(1.01%) 
RHE Isolindleyin MS2 [477] (CE:50%): 313(100), 169(55), 
125(25) [14] 
N28 555 [M-H]- NA RHE MS2 [555](CE:15-35V): 255, 227 [19] 
Table S3 Putatively identified compounds in the LC-MS/MS in negative ionization mode. 
Rt  
(min) 
No. m/z Adduct 
ion(s) 
MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
591 [M+Cl]- 477 (100%), 137 (12.97%) Desoxyrhaponticin-6''-O-
gallate  
N29 547 [M-H]- 547 (100%), 337 (30.32%), 457 (14.43%), 427 (13.69%), 367 (12.56%), 487 
(6.97%), 280 (5.16%), 409 (2.45%), 529 (1.42%), 349 (1.42%) 
SCU Chrysin-6-C-arabinosyl-8-
C-glucoside 
MS2 [547] (CE:NA): 529, 487, 457, 427, 
367, 337 [20] 
36.56 N30 477 [M-H]- 313 (100%), 477 (22.45%), 169 (17.33%), 151 (6.47%), 124 (6.44%), 123 
(6.14%), 168 (4.76%), 163 (4.52%), 125 (4.31%), 167 (3.65%), 113 (3.28%), 107 
(2.31%), 211 (2.14%), 433 (1.87%), 223 (1.16%), 268 (1.09%), 101 (1.06%), 253 
(1.03%), 269 (0.89%), 153 (0.54%), 209 (0.52%), 165 (0.43%), 251 (0.4%), 162 
(0.39%), 193 (0.32%), 179 (0.32%) 
RHE Lindleyin MS2 [477] (CE:50%): 313(100), 169(55), 
125(25) [14] 




591 [M+FA-H]- 477 (100%), 313 (90.2%), 507 (25.16%), 330 (18.66%), 476 (10.52%) 
955 [2M-H]- 477 (100%), 313 (56.56%) 
37.25 N32 547 [2M-H]- 547 (100%), 427 (13.87%), 457 (8.35%), 337 (6.72%), 479 (5.77%), 367 
(5.04%), 265 (2.76%), 529 (2.12%), 101 (1.98%), 281 (1.6%), 309 (1.19%), 379 
(0.82%), 349 (0.73%), 308 (0.68%), 397 (0.6%), 307 (0.57%), 511 (0.51%), 266 
(0.5%), 278 (0.5%), 439 (0.5%), 279 (0.48%), 469 (0.45%), 291 (0.41%), 409 
(0.41%), 335 (0.41%), 377 (0.41%), 336 (0.4%) 
SCU Chrysin-6-C-glucosyl-8-C-
arabonoside 
MS2 [547] (CE:NA): 529, 487, 457, 427, 
367, 337 [20] 
38.43 N33 541 [M-H]- 313 (100%), 227 (20.57%), 169 (18.22%), 541 (17.99%), 151 (9.27%), 312 
(4.29%), 123 (3.42%), 124 (2.09%) 
RHE Resveratrol-4'-O-β-D-(2''-
O-galloyl) glucoside  
MS2 [541] (CE:50%): 313(100), 227(25), 
169(40), 125(10) [14] 
39.20 N34 541 [M-H]- 541 (100%), 313 (25.58%), 169 (12.97%), 227 (6.46%), 125 (2.62%), 124 
(2.14%), 123 (1.46%), 151 (1.22%), 181 (1.07%), 241 (1.02%), 168 (0.74%), 540 
(0.69%), 211 (0.62%) 
 Resveratrol-4'-O-β-D-(6''-
O-galloyl) glucoside  
MS2 [541] (CE:50%): 313(100), 227(25), 
169(40), 125(10) [14]  
45.08 N35 301 [M-H]- 139 (100%), 124 (44.12%), 133 (28.08%), 135 (25.92%), 107 (23.4%), 161 
(17.74%), 273 (3.81%), 268 (3.35%), 283 (3.32%), 165 (3.24%), 240 (3.04%), 
269 (2.94%), 151 (2.73%), 251 (2.55%), 179 (2.35%), 160 (2.3%), 134 (2.27%), 






46.91 N36 431 [M-H]- 269 (100%), 431 (84.39%), 240 (14.94%), 225 (3.77%), 268 (2.54%), 283 







Aloe emodin 8- O-β-D-glucoside 
MS2 [431] (CE:15-35V): 269, 240 [19] 
 
Aloe-emodin-3-CH2-O-β-D-glycoside 
MS2 [431] (CE:15-35V): 269, 268 [19] 
 
Emodin 1-O-β-D-glucoside 




MS2 [431] (CE:25%): 311, 293, 269, 
268; MS3 [431269]: 269, 241, 225; 
MS4 [431269225]: 210, 182 [21] 
55.48 N37 481 [M+Cl]- NA SOP (-)-Maackiain-3-O-
glucoside (Trifolirhizin) 
NA 
483 [M+K-2H]- NA 
491 [M+FA-H]- 283 (100%), 255 (10.61%), 254 (4.06%) 
Table S3 Putatively identified compounds in the LC-MS/MS in negative ionization mode. 
Rt  
(min) 
No. m/z Adduct 
ion(s) 
MS/MS fragment ions (m/z) Source Identity Reported MS/MS fragments 
(CE=collision energy) 
58.94 N38 431 [M-H]- 269 (100%), 431 (38.42%), 268 (11.89%), 311 (4.38%), 225 (2.53%), 293 
(2.48%), 265 (1.93%), 240 (1.6%), 241 (1.29%), 239 (0.87%), 224 (0.68%), 270 







Aloe emodin 8- O-β-D-glucoside 
MS2 [431] (CE:15-35V): 269, 240 [19] 
 
Aloe-emodin-3-CH2-O-β-D-glycoside 
MS2 [431] (CE:15-35V): 269, 268 [19] 
 
Emodin 1-O-β-D-glucoside 




MS2 [431] (CE:25%): 311, 293, 269, 
268; MS3 [431269]: 269, 241, 225; 
MS4 [431269225]: 210, 182 [21] 
63.95 N39 233 [M-H]- 191 (100%), 233 (74.34%), 147 (16.22%), 175 (13.72%), 173 (9.55%), 190 
(5.6%), 149 (5.1%), 217 (5.08%), 215 (4.04%), 123 (3.6%), 145 (2.65%), 189 




MS2 [233](CE:30-50V): 189,  175, 147 
[13] 
71.02 N40 269 [M-H]- 269 (100%), 223 (11.25%), 241 (9.54%), 251 (7.35%), 169 (7.09%), 195 
(6.82%), 197 (5.46%), 137 (5.03%), 167 (4.17%), 139 (3.69%), 179 (3.12%), 141 
(2.68%), 171 (2.6%), 213 (2.35%), 207 (2.16%), 225 (2%), 151 (1.89%), 153 
(1.52%), 183 (1.48%), 143 (1.46%), 185 (1.34%), 224 (1.28%), 145 (1.25%), 123 
(1.24%), 240 (1.05%), 212 (0.98%), 199 (0.95%), 155 (0.92%), 157 (0.92%), 196 
(0.9%), 165 (0.88%), 181 (0.86%), 111 (0.83%), 268 (0.72%), 164 (0.64%), 101 
(0.61%), 127 (0.57%), 109 (0.51%), 184 (0.51%), 168 (0.47%), 192 (0.45%), 150 
(0.41%), 239 (0.4%), 182 (0.38%), 222 (0.37%), 198 (0.36%), 252 (0.36%), 125 
(0.35%), 180 (0.33%), 129 (0.31%), 221 (0.28%), 178 (0.27%), 211 (0.26%), 152 
(0.25%), 117 (0.24%), 270 (0.24%), 122 (0.24%), 121 (0.2%), 227 (0.19%), 138 






MS2 [269](CE:45% of maximum): 
251(100), 241(40), 225(40), 223(40); 
MS3 [269251]: 223(100) [22] 
 
Norwogonin: 
MS2 [269](CE:NA): 251, 241, 223, 197, 
195, 179, 169, 167, 151, 137, 123, 117 
[23] 
 
MS2 [269](CE:45% of maximum): 
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Fig. S2 Total ion chromatogram of DIC in a) negative and b) positive ionization mode.  
Counts vs. Acquisition Time (min)  
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Counts vs. Acquisition Time (min)  
b) 
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Counts vs. Acquisition Time (min)  
Counts vs. Acquisition Time (min)  
Fig. S7 Total ion chromatogram of SOP in a) negative and b) positive ionization mode.  






































































R =  
 = Sophocarpine 




































































































R =  
 = Oxysophoridine 




























    
N1 Glucuronic acid N2 Quinic acid N3 Sinapiic acid N4 Citric acid 
 
   






N5/N6/N7/N10 Gallic acid-4-O-β-D-glucoside N8 Pyrogallol N9 Gallic acid 
 
  
N11 Piscidic acid N12 Procyanidin B (Catechin dimers) 
 
















































N13/N18   
 
N14 Chlorogenic acid 
  
N15 3-O-Feruloylquinic acid N16 4-(4'-Hydroxylphenyl)-2-butanone 4'-O-β-D-glucoside 
  
N17 6-Hydroxymusizin-8-O- β-D-glucoside                                               N19 Jatrorrhizine 
  
N20 2',3,5,6',7-Pentahydroxyflavanone (Ganhuangemin) N21 5-O-Feruloylquinic acid 
  
N22 Resveratrol 3-O-ß-glucoside N22_Resveratrol 4'-O-ß-glucoside 
  
































R =  
OH = Catechin 







N23 Melezitose N24 Osthenol 
  
N25 3,5,7,2',6'-Pentahydroxyflavone (Viscidulin I) N26 Epicatechin 3-O-gallate 
  
N27 Isolindleyin N28 Desoxyrhaponticin-6''-O-gallate 
  
N29 Chrysin-6-C-arabinosyl-8-C-glucoside N30 Lindleyin 
 



























N31 Rhein-8-O-D-[6'-O-(3''-methoxylmalonyl)] glucoside N32 Chrysin-6-C-glucosyl-8-C-arabonoside 
  



































N36/N38_Aloe-emodin-3-CH2-O-ß-D-glucoside N36/N38_Aloe-emodin 8-O-ß-D-glucoside 
  


















Fig. S11 Chemical structure of (-)-9α-
Hydroxy-7, 11-dehydromatrine 
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